Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S BARTLETT

Showing results (131-140 of 386) with videos related to

Pageof 39
Sort By:
Antimicrobial Agents and Chemotherapy|September 1, 1987
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infectionS F Queener, M S Bartlett, M A Jay, et al.
The Journal of Pathology|July 8, 2003
Expression of the HER1-4 family of receptor tyrosine kinases in breast cancerCaroline J Witton, Jonathan R Reeves, James J Going, et al.
Genome Medicine|June 30, 2017
ISOWN: accurate somatic mutation identification in the absence of normal tissue controlsIrina Kalatskaya, Quang M Trinh, Melanie Spears, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
HER2 and COX2 expression in human prostate cancerJ Edwards, R Mukherjee, A F Munro, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis cariniiM D Ball, M S Bartlett, M Shaw, et al.
FEMS Microbiology Letters|December 15, 1995
Pteroylpolyglutamate synthesis by lung- and culture-derived Pneumocystis cariniiY L Hong, M S Bartlett, S Queener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridizationJorma Isola, Minna Tanner, Amanda Forsyth, et al.
Breast Cancer Research and Treatment|September 28, 2006
Bad expression predicts outcome in patients treated with tamoxifenElizabeth Cannings, Tove Kirkegaard, Sian M Tovey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?Sian Tovey, Barbara Dunne, Caroline J Witton, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Interactions between MAP kinase and oestrogen receptor in human breast cancerLiane M McGlynn, Sian Tovey, John M S Bartlett, et al.
Pageof 39

Showing results (131-140 of 386) with videos related to

Sort By:
Pageof 39
Antimicrobial Agents and Chemotherapy|September 1, 1987
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infectionS F Queener, M S Bartlett, M A Jay, et al.
The Journal of Pathology|July 8, 2003
Expression of the HER1-4 family of receptor tyrosine kinases in breast cancerCaroline J Witton, Jonathan R Reeves, James J Going, et al.
Genome Medicine|June 30, 2017
ISOWN: accurate somatic mutation identification in the absence of normal tissue controlsIrina Kalatskaya, Quang M Trinh, Melanie Spears, et al.
European Journal of Cancer (Oxford, England : 1990)|December 23, 2003
HER2 and COX2 expression in human prostate cancerJ Edwards, R Mukherjee, A F Munro, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis cariniiM D Ball, M S Bartlett, M Shaw, et al.
FEMS Microbiology Letters|December 15, 1995
Pteroylpolyglutamate synthesis by lung- and culture-derived Pneumocystis cariniiY L Hong, M S Bartlett, S Queener, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 23, 2004
Interlaboratory comparison of HER-2 oncogene amplification as detected by chromogenic and fluorescence in situ hybridizationJorma Isola, Minna Tanner, Amanda Forsyth, et al.
Breast Cancer Research and Treatment|September 28, 2006
Bad expression predicts outcome in patients treated with tamoxifenElizabeth Cannings, Tove Kirkegaard, Sian M Tovey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2005
Can molecular markers predict when to implement treatment with aromatase inhibitors in invasive breast cancer?Sian Tovey, Barbara Dunne, Caroline J Witton, et al.
European Journal of Cancer (Oxford, England : 1990)|December 26, 2012
Interactions between MAP kinase and oestrogen receptor in human breast cancerLiane M McGlynn, Sian Tovey, John M S Bartlett, et al.
Pageof 39